Import tariffs, duties and sales taxes on medicines, medical devices, and the ingredients to make pharmaceuticals block access to medicines in the developing world, including Brazil, according to a new working paper published by the AEI - Brookings Joint Center in Washington, DC.

Comments (0)

Subscribe to this comment's feed

Name

Email

Website

Title

Comment

smaller | bigger

Subscribe via email (Registered users only)

Write the displayed characters

Add Comment

---